
The measles vaccine is given to prevent measles in children and adults. Antibodies to the measles virus are produced in 95% of vaccinated individuals within 3-4 weeks. The validity of the measles vaccine is 15-20 years.
The measles vaccine is given to prevent measles in children and adults. Antibodies to the measles virus are produced in 95% of vaccinated individuals within 3-4 weeks. The validity of the measles vaccine is 15-20 years.
Active measles prevention in children and adults.
Formation of immunity against measles for a period of up to 15-20 years.
Vaccination is temporarily or absolutely contraindicated in case of progressive pathology of the nervous system, as well as in cases where seizures have occurred that are not associated with fever.
Children from 1 year old.
Revaccination at 6 years of age.
Emergency vaccination is carried out within 3 days in case of contact with a patient, in the absence of primary vaccination.
The name of the vaccine | Country | Composition and form of release | Price |
---|---|---|---|
Prioryx | Belgium | suspension for injection | 1200 UAH |